These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
878 related articles for article (PubMed ID: 34114269)
1. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination. Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269 [TBL] [Abstract][Full Text] [Related]
2. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. Dang YL; Bryson A BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426 [TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients. Kanabar G; Wilkinson P BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34649856 [TBL] [Abstract][Full Text] [Related]
4. Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome. Meo SA; Shaikh N; Abukhalaf FA; Meo AS Sci Rep; 2024 Aug; 14(1):18767. PubMed ID: 39138276 [TBL] [Abstract][Full Text] [Related]
5. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link? Oo WM; Giri P; de Souza A J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365 [TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome after COVID-19 vaccination. McKean N; Chircop C BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330729 [TBL] [Abstract][Full Text] [Related]
11. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination. Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134 [TBL] [Abstract][Full Text] [Related]
12. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines. García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212 [TBL] [Abstract][Full Text] [Related]
13. Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023. Jeong YD; Park S; Lee S; Jang W; Park J; Lee K; Lee J; Kang J; Udeh R; Rahmati M; Yeo SG; Smith L; Lee H; Yon DK Sci Rep; 2024 Oct; 14(1):24561. PubMed ID: 39427003 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database. Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP; Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300 [TBL] [Abstract][Full Text] [Related]
15. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia. Sii HL; Ng SH; Wong VF; Law WC Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913 [TBL] [Abstract][Full Text] [Related]
16. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review. Liang H; Cao Y; Zhong W; Ma Z; Liu J; Chen H Hum Vaccin Immunother; 2022 Nov; 18(6):2125753. PubMed ID: 36315834 [TBL] [Abstract][Full Text] [Related]
17. Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2. Leung C Hum Vaccin Immunother; 2021 Sep; 17(9):2957-2958. PubMed ID: 34032555 [TBL] [Abstract][Full Text] [Related]
18. The First Guillain-Barr? Syndrome After SARS-CoV-2 Vaccination in Taiwan. Su SC; Lyu RK; Chang CW; Tseng WJ Acta Neurol Taiwan; 2022 Jan; 31(1)():46-51. PubMed ID: 34988954 [TBL] [Abstract][Full Text] [Related]
19. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Min YG; Ju W; Ha YE; Ban JJ; Lee SA; Sung JJ; Shin JY J Neuroimmunol; 2021 Oct; 359():577691. PubMed ID: 34416410 [TBL] [Abstract][Full Text] [Related]
20. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Tutar NK; Eyigürbüz T; Yildirim Z; Kale N Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]